Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
A Double-blind, Placebo-controlled Study of Lumateperone in the Treatment of Borderline Personality Disorder.
Journal: Clinical neuropharmacology
Published: April 08, 2026
An Open-Label Study of Single-Dose Psilocybin for Borderline Personality Disorder With Co-Occurring Major Depressive Disorder.
Journal: Clinical neuropharmacology
Published: January 29, 2026
Preferences for Pre-Exposure Prophylaxis Implementation and Engagement in the HIV Pre-Exposure Prophylaxis Care Continuum Among Patients Receiving Psychiatric Care in an Ending the HIV Epidemic Priority County.
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: December 22, 2024
Psychiatrists' Experiences, Training Needs, and Preferences Regarding Prescription and Management of HIV Pre-exposure Prophylaxis (PrEP) Within Psychiatric Care.
Journal: Psychiatric research and clinical practice
Published: May 16, 2024
Trichotillomania in sexual minority individuals.
Journal: Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists
Published: October 18, 2023
Double-Blind Placebo-Controlled Study of Memantine in Trichotillomania and Skin-Picking Disorder.
Journal: The American journal of psychiatry
Published: March 01, 2023
A double-blind placebo-controlled study of brexpiprazole for the treatment of borderline personality disorder.
Journal: The British journal of psychiatry : the journal of mental science
Published: January 20, 2022
Tetrahydrocannabinol fails to reduce hair pulling or skin picking: results of a double-blind, placebo-controlled study of dronabinol.
Journal: International clinical psychopharmacology
Published: November 26, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026